Table 4.
COGNITIVE TEST | TICS | GLOBAL SCORE | VERBAL SCORE |
---|---|---|---|
Amyloid β 40:42 Ratio | |||
Age/education-adjusted | −0.08 (−0.15, −0.01) | −0.02 (−0.04, −0.00) | −0.02 (−0.04, 0.01) |
p-trend† | 0.02 | 0.03 | 0.16 |
Multivariable-adjusted‡ | −0.08 (−0.15, −0.01) | −0.02 (−0.04, −0.00) | −0.02 (−0.04, 0.01) |
p-trend† | 0.02 | 0.03 | 0.18 |
Amyloid β 42 | |||
Age/education-adjusted | 0.03 (−0.03, 0.10) | 0.01 (−0.01, 0.02) | −0.00 (−0.03, 0.02) |
p-trend† | 0.32 | 0.56 | 0.67 |
Multivariable-adjusted‡ | 0.04 (−0.03, 0.11) | 0.01 (−0.01, 0.02) | −0.01 (−0.03, 0.02) |
p-trend† | 0.31 | 0.57 | 0.65 |
Mean (range) cognitive testing interval was 4.1 (3.1 − 5.5) years.
Linear trend for each SD increase in percent change of Aβ−40:Aβ−42 ratio or Aβ−42. Mean (range) interval between first and second plasma collection was 11.1 (9.2 − 12.2) years.
Models adjusted for age at baseline interview and education; cigarette smoking, postmenopausal hormone use, hypertension, elevated cholesterol, body mass index, alcohol intake and physical activity level as of blood draw; and depression status as of start of cognitive testing.